Faecalibacterium prausnitzii: from microbiology to diagnostics and prognostics
There is an increasing interest in Faecalibacterium prausnitzii , one of the most abundant bacterial species found in the gut, given its potentially important role in promoting gut health. Although some studies have phenotypically characterized strains of this species, it remains a challenge to dete...
Saved in:
Published in | The ISME Journal Vol. 11; no. 4; pp. 841 - 852 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
London
Nature Publishing Group UK
01.04.2017
Oxford University Press Nature Publishing Group |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | There is an increasing interest in
Faecalibacterium prausnitzii
, one of the most abundant bacterial species found in the gut, given its potentially important role in promoting gut health. Although some studies have phenotypically characterized strains of this species, it remains a challenge to determine which factors have a key role in maintaining the abundance of this bacterium in the gut. Besides, phylogenetic analysis has shown that at least two different
F. prausnitzii
phylogroups can be found within this species and their distribution is different between healthy subjects and patients with gut disorders. It also remains unknown whether or not there are other phylogroups within this species, and also if other
Faecalibacterium
species exist. Finally, many studies have shown that
F. prausnitzii
abundance is reduced in different intestinal disorders. It has been proposed that
F. prausnitzii
monitoring may therefore serve as biomarker to assist in gut diseases diagnostics. In this mini-review, we aim to serve as an overview of
F. prausnitzii
phylogeny, ecophysiology and diversity. In addition, strategies to modulate the abundance of
F. prausnitzii
in the gut as well as its application as a biomarker for diagnostics and prognostics of gut diseases are discussed. This species may be a useful potential biomarker to assist in ulcerative colitis and Crohn’s disease discrimination. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Review-3 content type line 23 |
ISSN: | 1751-7362 1751-7370 1751-7370 |
DOI: | 10.1038/ismej.2016.176 |